Mastitis Market Segmentation by Treatment (Antibiotics, and Others); by End User (Hospitals, Academic Institutes, Hospital & Clinics, and Others); and by Type (Clinical, and Sub-Clinical Intramammary Inflammation)-Global Demand Analysis & Opportunity Outlook 2031
-
Product Code:
RP-ID-10078505 -
Published Date:
27 Oct 2022 -
Region:
Global
-
Category:
Healthcare & Pharmaceuticals -
Publisher:
Pub-ID-54
Impact Analysis on the Growth of Market
Inflation and Looming Recession to Haunt Businesses:
In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.
....
The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.
With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.
Market Overview:
Translate Report
Global Mastitis Market Highlights Over 2022- 2031
The global mastitis market is estimated to grow at a ~5% CAGR over the forecast period, i.e., 2022 – 2031. Moreover, the market registered a revenue of approximately USD 2.0 billion in 2021. The growth of the market can be attributed to the rising cases of mastitis that are expected to affect the growth of the countries’ GDP through a reduction in milk production, the degradation milk quality, and others. As per the International Dairy Foods Association, the dairy industry contributes 3.5 percent of the U.S. GDP. Furthermore, the increase in the number of cattle herds and the rise in the fertility rate are also anticipated to surge the growth of the global mastitis market.
GET A SAMPLE COPY OF THIS REPORT
The global mastitis market is segmented by type into clinical, and sub-clinical intramammary inflammation. Out of these, the clinical intramammary inflammation segment is anticipated to hold the largest share over the forecast period owing to the increase in the number of cases of clinical intramammary inflammation in dairy cattle and the growing number of dairy animals.
Global Mastitis Market Regional Synopsis
Regionally, the global mastitis market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in the Asia Pacific region is estimated to witness modest growth over the forecast period on the back of the rise in the pregnancy rates and an increase in the cattle population. According to the United Nations Children’s Fund, every day approximately 67,385 babies are born in India, which accounts for one-sixth of the worldwide child births. Moreover, the rise in the number of mastitis cases and the number of people suffering from chronic diseases is anticipated to surge the growth of the mastitis market in the Asia Pacific region.
Market Segmentation
Our in-depth analysis of the global mastitis market includes the following segments:
By Treatment
-
Antibiotics
-
Vaccines
-
Others
By End User
-
Hospitals
-
Academic Institutes
-
Hospital & Clinics
-
Others
By Type
-
Clinical
-
Sub-Clinical Intramammary Inflammation
Growth Drivers and Challenges Impacting the Growth of the Global Mastitis Market
Growth Drivers
-
Rising cases of mastitis that are expected to affect the growth of the countries’ GDP
-
Increase in the number of cattle herds
Challenges
-
Lack of knowledge among the people related to mastitis
-
Lack of resources with farmers for the treatment of their cattle
Key Companies Dominating the Global Mastitis Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global mastitis market that are included in our report are Bayer AG, Pfizer Inc., Elanco, Ceva, Boehringer Ingelheim International GmbH., Sanofi, Novartis AG, Merck & Co., Inc., Astellas Pharma Inc., F. Hoffmann-La Roche Ltd, and others.
Latest Developments in the Global Mastitis Market:
-
15 April 2021: Ingelheim Boehringer Ingelheim GmbH., announced that its Ubroseal internal teat sealant was upgraded to Ubroseal Blue. As part of the Company's mastitis portfolio, Ubroseal Blue will be available in selected countries worldwide.
-
19 July 2019: Sure Petcare (Merck & Co., Inc.,) announced the release of the SureFeed Microchip Pet Feeder Connect, the next generation of the best-selling SureFeed Microchip Pet Feeder, which monitors pets' eating habits. The smart feeder tracks how much and when a pet eats and sends real-time updates to the owner's phone.
Key Reasons to Buy Our Report
-
The report covers a detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis, and challenges that impact market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessments for overall growth.
-
We provide customized reports as per the client's requirements helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
Geography Analysis:
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
.
FREQUENTLY ASKED QUESTIONS
Rising cases of mastitis that will affect the growth of the countries’ GDP and an increase in the number of cattle herds are the major factors driving the growth of the mastitis market.
The market is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2022-2031.
Lack of knowledge among the people related to mastitis and lack of resources with farmers for the treatment of their cattle are estimated to hamper the market growth.
Asia Pacific region will provide more business opportunities for growth of mastitis market in future.
The major players in the market are Bayer AG, Pfizer Inc., Elanco, Ceva, Boehringer Ingelheim International GmbH., Sanofi, Novartis AG, Merck & Co., Inc., Astellas Pharma Inc., F. Hoffmann-La Roche Ltd, and others.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by type, treatment, end-user, and by region.
The clinical intramammary inflammation segment is anticipated to hold largest market size in value over the forecast period and display significant growth opportunities.
Please enter your personal details below
- Bayer AG
- Pfizer Inc.
- Elanco
- Ceva
- Boehringer Ingelheim International GmbH.
- Sanofi
- Novartis AG
- Merck & Co.Inc.
- Astellas Pharma Inc.
- F. Hoffmann-La Roche Ltd